These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18226466)

  • 1. Particle therapy in lung cancer: where do we stand?
    Pijls-Johannesma M; Grutters JP; Lambin P; Ruysscher DD
    Cancer Treat Rev; 2008 May; 34(3):259-67. PubMed ID: 18226466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review.
    Pijls-Johannesma M; Grutters JP; Verhaegen F; Lambin P; De Ruysscher D
    Oncologist; 2010; 15(1):93-103. PubMed ID: 20067947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis.
    Grutters JP; Kessels AG; Pijls-Johannesma M; De Ruysscher D; Joore MA; Lambin P
    Radiother Oncol; 2010 Apr; 95(1):32-40. PubMed ID: 19733410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heavy-ion therapy for non-small cell lung cancer].
    Miyamoto T; Yamamoto N; Koto M; Nishimura H; Tsujii H; Fujisawa T
    Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):250-5. PubMed ID: 11904989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heavy ion therapy for non-small cell lung cancer--new, radical radiotherapy for advanced-age patients as an alternative to surgery].
    Miyamoto T
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):209-14. PubMed ID: 12610868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer.
    Iwata H; Murakami M; Demizu Y; Miyawaki D; Terashima K; Niwa Y; Mima M; Akagi T; Hishikawa Y; Shibamoto Y
    Cancer; 2010 May; 116(10):2476-85. PubMed ID: 20225229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
    Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Particle therapy--carbon ion radiotherapy for non-small cell lung cancer].
    Yamamoto N; Baba M; Nakajima M; Kamada T; Tsujii H
    Nihon Rinsho; 2010 Jun; 68(6):1040-4. PubMed ID: 20535953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer.
    Iwata H; Demizu Y; Fujii O; Terashima K; Mima M; Niwa Y; Hashimoto N; Akagi T; Sasaki R; Hishikawa Y; Abe M; Shibamoto Y; Murakami M; Fuwa N
    J Thorac Oncol; 2013 Jun; 8(6):726-35. PubMed ID: 23459403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COST-ENLIGHT strategic workshop on hadron (particle) therapy, CERN, Geneva, 3-4 May 2007.
    Taylor RE
    Br J Radiol; 2008 Mar; 81(963):169-71. PubMed ID: 18208851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle therapy at the Heidelberg Ion Therapy Center (HIT) - Integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany.
    Combs SE; Jäkel O; Haberer T; Debus J
    Radiother Oncol; 2010 Apr; 95(1):41-4. PubMed ID: 20227124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heavy ion therapy for lung cancer].
    Miyamoto T
    Nihon Rinsho; 2002 May; 60 Suppl 5():424-8. PubMed ID: 12101706
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer.
    Oshiro Y; Mizumoto M; Okumura T; Hashimoto T; Fukumitsu N; Ohkawa A; Kanemoto A; Hashii H; Ohno T; Sakae T; Tsuboi K; Sakurai H
    J Thorac Oncol; 2012 Feb; 7(2):370-5. PubMed ID: 22157368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
    Peeters A; Grutters JP; Pijls-Johannesma M; Reimoser S; De Ruysscher D; Severens JL; Joore MA; Lambin P
    Radiother Oncol; 2010 Apr; 95(1):45-53. PubMed ID: 20106540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer.
    Lee CB; Stinchcombe TE; Moore DT; Morris DE; Hayes DN; Halle J; Rosenman JG; Rivera MP; Socinski MA
    J Thorac Oncol; 2009 Jan; 4(1):74-9. PubMed ID: 19096310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerators for heavy-charged-particle radiation therapy.
    Coutrakon GB
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):49-54. PubMed ID: 17668952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose proton beam therapy for Stage I non-small-cell lung cancer.
    Nihei K; Ogino T; Ishikura S; Nishimura H
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):107-11. PubMed ID: 16458447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research.
    Grutters JP; Pijls-Johannesma M; Ruysscher DD; Peeters A; Reimoser S; Severens JL; Lambin P; Joore MA
    Cancer Treat Rev; 2010 Oct; 36(6):468-76. PubMed ID: 20303217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton beam therapy of Stage II and III non-small-cell lung cancer.
    Nakayama H; Satoh H; Sugahara S; Kurishima K; Tsuboi K; Sakurai H; Ishikawa S; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):979-84. PubMed ID: 20888140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.